Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Schellenberg

Showing results (1-10 of 503) with videos related to

Pageof 51
Sort By:
Current Opinion in Neurology|August 1, 1995
Progress in Alzheimer's disease geneticsG D Schellenberg
Archives of Neurology|November 19, 2003
Alzheimer disease genes: presenilin 2 mutation number 9 and still countingGerard D Schellenberg
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Early Alzheimer's disease geneticsGerard D Schellenberg
Proceedings of the National Academy of Sciences of the United States of America|September 12, 1995
Genetic dissection of Alzheimer disease, a heterogeneous disorderG D Schellenberg
Arzneimittel-Forschung|March 1, 1995
Molecular genetics of familial Alzheimer's diseaseG D Schellenberg
Neurobiology of Aging|January 1, 1994
Alzheimer's disease: implications of genetic studiesG D Schellenberg
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|August 1, 1996
[STM-2, a candidate gene for the familial Alzheimer's disease on chromosome 1]J Oshima, G D Schellenberg
The Journal of Biological Chemistry|May 10, 2002
tau Exon 10 expression involves a bipartite intron 10 regulatory sequence and weak 5' and 3' splice sitesIan D'Souza, Gerard D Schellenberg
The Journal of Biological Chemistry|April 5, 2000
Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusionI D'Souza, G D Schellenberg
The Journal of Clinical Pharmacology and New Drugs|February 1, 1972
Clindamycin palmitate flavored granules. Multidose tolerance, absorption, and urinary excretion study in healthy childrenR M DeHaan, D Schellenberg
Pageof 51

Showing results (1-10 of 503) with videos related to

Sort By:
Pageof 51
Current Opinion in Neurology|August 1, 1995
Progress in Alzheimer's disease geneticsG D Schellenberg
Archives of Neurology|November 19, 2003
Alzheimer disease genes: presenilin 2 mutation number 9 and still countingGerard D Schellenberg
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Early Alzheimer's disease geneticsGerard D Schellenberg
Proceedings of the National Academy of Sciences of the United States of America|September 12, 1995
Genetic dissection of Alzheimer disease, a heterogeneous disorderG D Schellenberg
Arzneimittel-Forschung|March 1, 1995
Molecular genetics of familial Alzheimer's diseaseG D Schellenberg
Neurobiology of Aging|January 1, 1994
Alzheimer's disease: implications of genetic studiesG D Schellenberg
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|August 1, 1996
[STM-2, a candidate gene for the familial Alzheimer's disease on chromosome 1]J Oshima, G D Schellenberg
The Journal of Biological Chemistry|May 10, 2002
tau Exon 10 expression involves a bipartite intron 10 regulatory sequence and weak 5' and 3' splice sitesIan D'Souza, Gerard D Schellenberg
The Journal of Biological Chemistry|April 5, 2000
Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusionI D'Souza, G D Schellenberg
The Journal of Clinical Pharmacology and New Drugs|February 1, 1972
Clindamycin palmitate flavored granules. Multidose tolerance, absorption, and urinary excretion study in healthy childrenR M DeHaan, D Schellenberg
Pageof 51